OVERVIEW

Beyond Daily Injections:Implementing Once-Weekly Basal Insulin to Simplify and Personalize Care is organized by Medical Learning Institute Inc (MLI).

Release Date: Sep 18, 2026
Expiration Date: Sep 17, 2027

Description:
Beyond Daily Injections: Implementing Once-Weekly Basal Insulin to Simplify and Personalize Care is designed for US-based endocrinologists and endocrinology-focused NPs and PAs involved in the management of patients with type 2 diabetes (T2D). Once-weekly basal insulin regimens are poised to enter the treatment armamentarium for diabetes management. Gaps in understanding the unique molecular design and pharmacology of, and latest clinical data on these novel formulations may contribute to therapeutic inertia and delayed implementation of a more convenient, flexible, and potentially safer alternative to daily insulin regimens for patients with T2D.

This interactive Real Answers to Real Questions CME activity will integrate extensive peer-to-peer discussion into didactive presentation elements and provide clinicians with the opportunity to examine the recent scientific advancements related to once-weekly basal insulins and compare their pro and cons with traditional once-daily basal insulin regimens. By tackling real-world, practical questions that endocrinologists and endocrinology-focused NPs and PAs face every day, the activity will prepare these clinicians to confidently integrate once-weekly basal insulins into patient-centered diabetes care when they become available.

Learning Objectives:
After completing this activity, the participant should be better able to:

  • Differentiate emerging once-weekly basal insulins from traditional once-daily formulations based on molecular structure, mechanism of action, and pharmacokinetic/pharmacodynamic properties
  • Interpret the efficacy and safety data of once-weekly basal insulins in late-stage development
  • Develop a comprehensive, individualized evidence-based treatment plan for patients with type 2 diabetes who require basal insulin that incorporates best practices for initiation, dosing, and titration
Credits

Credits:
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education:
Medical Learning Institute Inc (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).

For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.

Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval if valid until September 17, 2027. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development:
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and 1.0 contact hour(s) in the area of pharmacology.

Interprofessional Continuing Education (IPCE) Statement:
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

  • 1 AMA PRA Category 1 Credits™
  • 1 MOC
  • 1 AAPA
  • 1 CME
  • 1 Contact Hours
  • 1 IPCE

    • TARGET AUDIENCE

    PhysicianNursingPhysician AssistantEndocrinologistsNurse Practitioners

    SPECIALITIES

    Endocrinology
    Register your interest in this activity to receive updates when the registration is open.
    Scan to download eMedEvents app

    Download eMedEvents Mobile App

    Track your CE certificates and CME requirements anytime, anywhere.

    Download on App StoreGet it on Google Play

    RELATED ONLINE COURSES

    Mastering Emergency Medicine: Neurology, Hematology, & Endocrinology Essentials

    By CME4LIFE

    Webcast

    Emergency Medicine
    6.5 CME
    More actions
    US$699

    Washington Primary Care Physicians License Renewal CME Package - 109 CME Credits

    By eMedEd, Inc.

    Mar 28, 2022 - Nov 30, 2026 | Webcast

    State required course for Washington
    103.75 AMA PRA Category 1 Credits™
     ...
    More actions
    US$1,925.40

    Massachusetts Primary Care Physicians License Renewal CME Package - 45 CME Credits

    By eMedEd, Inc.

    Mar 28, 2022 - Nov 30, 2026 | Webcast

    State required course for Massachusetts
    45.25 AMA PRA Category 1 Credits™
     ...
    More actions
    US$749.50
    Quick Linksfooter

    Copyrights © 2026 eMedEvents Corporation, All Rights Reserved